Robots grow mini-organs from human stem cells
An automated system that uses robots has been designed to rapidly produce human mini-organs derived from stem cells.
Faculty in our Division of Nephrology focus on early detection, prevention and treatment of kidney disease and its complications.
- Development of the Scribner Shunt – the first successful arterio-venous access for chronic hemodialysis
- First site for erythropoietin trial in dialysis patients
- Beginning of medical ethics as a result of the early rationing of dialysis for a few select patients
- Establishment of the nation’s first Kidney Research Institute
- First clinical trial site for the wearable artificial kidney
- Center for Dialysis Innovation
Did you know?
Seattle has long been the place for kidney research. In 1960, Dr. Belding H. Scribner, the first director of nephrology at the University of Washington, and his colleagues developed a blood access device for hemodialysis called the Scribner shunt, providing a lifeline to patients with kidney failure.
The shunt allowed patients to receive lifesaving dialysis on a long-term basis, changing kidney failure from a death sentence to a treatable condition. Dr. Scribner subsequently founded Northwest Kidney Centers, the first outpatient dialysis program in the world, and made Seattle an international center for advances in kidney disease.